Manufacturer record

Arco Lifesciences (I) Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Arco Lifesciences (I) Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between January 2026 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: BD25G2, Bupivacaine Hydrochloride in Dextrose Injection USP 4ml (exp Jul 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to U.S.P. with respect to Assay of Dextrose Anhydrous. Listed in the August 2026 alert.

Records by type

2 records linked to Arco Lifesciences (I) Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2026 to Aug 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2026
1
Products affected
Assay
Most common failure
Aug 2026
Latest alert

Flagged batches per year

2026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Bupivacaine Hydrochloride in Dextrose Injection USP 4ml Batch BD25G2Mfg Aug 2025 · Exp Jul 2027 The sample does not conform to U.S.P. with respect to Assay of Dextrose AnhydrousAssay CDL, KolkataCDSCO lab Aug 2026
Bupivacaine Hydrochloride in Dextrose Injection USP Batch BD24D2Mfg Dec 2024 · Exp Nov 2026 The sample does not conform to U.S.P. with respect to test for Visible Particulates In Injection and Description.Description CDL, KolkataCDSCO lab Jan 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.